Non-Abelian Stokes Theorem and Quark Confinement in SU(3) Yang-Mills Gauge Theory

We derive a new version of SU(3) non-Abelian Stokes theorem by making use of the coherent state representation on the coset space $SU(3)/(U(1)\times U(1))=F_2$, the flag space. Then we outline a derivation of the area law of the Wilson loop in SU(3) Yang-Mills theory in the maximal Abelian gauge (The detailed exposition will be given in a forthcoming article). This derivation is performed by combining the non-Abelian Stokes theorem with the reformulation of the Yang-Mills theory as a perturbative deformation of a topological field theory recently proposed by one of the authors. Within this framework, we show that the fundamental quark is confined even if $G=SU(3)$ is broken by partial gauge fixing into $H=U(2)$ just as $G$ is broken to $H=U(1) \times U(1)$. An origin of the area law is related to the geometric phase of the Wilczek-Zee holonomy for U(2). Abelian dominance is an immediate byproduct of these results and magnetic monopole plays the dominant role in this derivation.Comment: 14 pages, Latex, no figures, version accepted for publication in Mod. Phys. Lett. A (some comments are added in the final parts

Construction of novel metabolic pathways with artificial enzymes

Non-fossil raw materials can be utilized for the production of useful compounds by way of microbial fermentation . Sugars are obtained from carbon fixations of plants or photosynthetic microorganisms, and are used as a carbon source for the biosynthesis of useful target compounds by genetically modified microorganisms. In order for a microorganism to produce enough target compound, techniques for optimal metabolic design must include balance of energy production/consumption, redox pathways, and intracellular carbon flow. With recent innovations in genome analysis technology and information processing technology, computational design tools that can describe more than 1000 genome-scale metabolic reactions to efficiently produce target compounds have been developed worldwide. However, the established tools are not designed to search and create biosynthetic pathways for production of non-natural compounds from fossil resources. We developed BioProV and M-path, new simulation tools that enable metabolic design for the biosynthesis of unnatural compounds. By combining these tools with enzyme engineering technology, we succeeded in expanding the scope of bioproduction targets. The first example is construction of an artificial metabolic pathway to biosynthesize isoprene. Isoprene the raw material for production of synthetic rubber that can be used in automobile tires. Currently, isoprene is industrially produced as a by-product of naphtha pyrolysis. Therefore, by establishing green isoprene production technology, dependence upon petroleum can be reduced. Isoprene is a substance that can exist within cells of many organisms as a monomer of polyisoprene rubber, and also as a structural unit of secondary metabolites. It is difficult to optimize its synthentic pathway due to shortages of intracellular ATP supply, and challenges in the introduction of improved biosynthetic pathways. In nature, isoprene is produced from mevalonic acid through a five-step reaction, but the newly constructed artificial metabolic pathway consists of just two steps from mevalonic acid to isoprene. This results in a three-fold reduction in cellular energy consumption. Furthermore, we succeeded in constructing a highly active enzyme that exhibits 10,000-fold higher isoprene-producing activity relative to natural enzymes. By introducing these artificial metabolic reactions into Escherichia coli, efficient artificial isoprene production was achieved. In addition, we have developed a microbial production system for 1,3-butadiene, another alternative source for synthetic rubber. Moreover, rationally engineered enzymes from insects and plants enzymes have resulted in the construction of an artificial pathway to benzylisoquinoline alkaloids and downstream opioid analgesics

Effects of a Rehabilitation Program Combined with Pain Management That Targets Pain Perception and Activity Avoidance in Older Patients with Acute Vertebral Compression Fracture: a Randomised Controlled Trial

This study aimed to investigate the efect of a rehabilitation program combined with pain management targeting pain perception and activity avoidance on multifaceted outcomes in older patients with acute vertebral compression fractures (VCFs). We randomised 65 older adults with acute VCFs to either an intervention group (n = 32), involving usual rehabilitation combined with pain management that targeted pain perception and activity avoidance, or a control group (n = 33), involving only usual rehabilitation. Te usual rehabilitation was initiated immediately after admission. All patients were treated conservatively. Pain management aimed to improve the patients’ daily behaviour by increasing their daily activities despite pain, rather than by focusing on eliminating the pain. Pain intensity and psychological statuses such as depression, pain catastrophising, and physical activity levels were assessed on admission. Two weeks postadmission and at discharge, physical performance measures were assessed along with the above-given measurements. A signifcant main efect of the group was observed for the intensity of lower back pain, favouring the intervention group (F = 5.135, p = 0.027). At discharge, it was signifcantly better in the intervention group than in the control group (p = 0.011). A time-by-group interaction emerged for magnifcation of the pain catastrophising scale (p = 0.012), physical activity levels (p < 0.001), and six-minute walking distance (p = 0.006), all favouring the intervention group. Rehabilitation programs combined with pain management targeting pain perception and activity avoidance could be an efective conservative treatment for older patients with acute VCFs

Past infections and low ACPA in RA

Background : Rheumatoid arthritis (RA), an autoimmune disease of unknown etiology, is believed to occur as the result of actions of genetic and environmental factors. In this study, we examined the relation of past histories about infectious diseases with the levels anti-citrullinated protein autoantibodies (ACPA) in RA. Methods : Results of a questionnaire about histories of infectious diseases were obtained from 85 patients with RA, and were analyzed. Results : Significantly lower level of ACPA was detected in patients with the history of tonsillitis, otitis media or urinary cystitis than in those without it. There was no difference in the level of ACPA in RA patients between with and without cold / influenza, rubella, chickenpox, herpes labialis or herpes zoster. When RA patients were divided into two groups, high-level and low-level ACPA, multiple logistic regression analysis revealed that the history of otitis media was a significantly independent factor for the low level of ACPA. There was no significant relation between the level of rheumatoid factor and histories of infectious diseases. Conclusion : This study clarified that the past history of otitis media is associated with the low level of ACPA in RA

Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice

新型コロナウイルスを中和するアルパカ抗体 --マウス実験で有効性を確認--. 京都大学プレスリリース. 2023-02-17.BACKGROUND: SARS-CoV-2 Omicron variants are highly resistant to vaccine-induced immunity and human monoclonal antibodies. METHODS: We previously reported that two nanobodies, P17 and P86, potently neutralize SARS-CoV-2 VOCs. In this study, we modified these nanobodies into trimers, called TP17 and TP86 and tested their neutralization activities against Omicron BA.1 and subvariant BA.2 using pseudovirus assays. Next, we used TP17 and TP86 nanobody cocktail to treat ACE2 transgenic mice infected with lethal dose of SARS-CoV-2 strains, original, Delta and Omicron BA.1. RESULTS: Here, we demonstrate that a novel nanobody TP86 potently neutralizes both BA.1 and BA.2 Omicron variants, and that the TP17 and TP86 nanobody cocktail broadly neutralizes in vitro all VOCs as well as original strain. Furthermore, intratracheal administration of this nanobody cocktail suppresses weight loss and prolongs survival of human ACE2 transgenic mice infected with SARS-CoV-2 strains, original, Delta and Omicron BA.1. CONCLUSIONS: Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice

Effect of exercise and/or educational interventions on physical activity and pain in patients with hip/knee osteoarthritis: A systematic review with meta-analysis

Objective: To investigate the effectiveness of exercise and/or educational intervention on physical activity and pain in patients with hip/knee osteoarthritis (OA) using systematic review and meta-analysis.Methods: We searched randomized controlled trials that investigated physical activity and pain and compared exercise and/or educational intervention with usual care in patients with hip/knee OA in MEDLINE (PubMed), ProQuest, Scopus, and the Physiotherapy Evidence Database (PEDro), including all those published by April 30, 2022 and written in English. Studies that newly applied analgesics after onset of the intervention were excluded. The revised Cochrane risk-of-bias tool for randomized trials was used to assess the methodological qualities. The random-effects model was used for meta-analysis with standard mean differences using RevMan version 5.4. The body of evidence for each study was synthesized using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.Results: Twenty studies including 2,350 patients were included (7 exercise studies, 8 educational intervention studies and 5 combination studies). The meta-analysis demonstrated that there is very low evidence that combination therapy of exercise and educational intervention improve the physical activity level at the endpoint (4 articles; SMD 0.33, 95% CI 0.04 to 0.51, P = 0.03). Low evidence was observed for combination therapy reducing pain (4 articles; SMD -0.15, 95% CI -0.29 to -0.02, P = 0.03).Discussion: The current evidence indicated that combination therapy of exercise and educational intervention leads to improved physical activity and pain reduction in hip/knee OA patients, but the risk of bias in each study, especially in allocation concealment, downgraded the evidence level. These findings support the use of a combination therapy of exercise and educational intervention to promote physical activity levels in patients with hip/knee OA.Trail registration: There was no financial support for this research. The protocol was registered at the International Prospective Register of Systematic Reviews (registration code: CRD42020205804)